• Product NameDarunavir
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityDarunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.
• Target NameHIV Protease inhibitor
• CAS No. 206361-99-1
• Calculated MW 547.66
• Formulation C27H37N3O7S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV Protease
  Boling pt:
  Melting pt:
  Solubility:DMSO: 150 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Fujimoto H, et al. Biol Pharm Bull, 2009, 32(9), 1588-1593.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting